Table 2 Results of pulmonary function tests and respiratory muscle strength among COVID-19 patients
From: Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase
Parameter | Total (n=57) | Severe (n=17) | Non-severe (n=40) | p Value |
|---|---|---|---|---|
FVC (% of predicted) | 100.96 (15.93) | 95.92 (19.59) | 103.10 (13.83) | 0.12 |
FEV1 (% of predicted) | 97.89 (14.91) | 93.93 (16.79) | 99.57 (13.92) | 0.194 |
FEV1/FVC(%) | 81.22 (6.13) | 80.58 (4.88) | 81.49 (6.62) | 0.614 |
TLC (% of predicted) | 93.94 (12.75) | 88.72 (16.20) | 96.22 (10.35) | 0.048* |
RV (% of predicted) | 90.68 (28.08) | 86.57 (23.96) | 92.47 (29.82) | 0.327 |
DLCO (% of predicted) | 78.38 (13.59) | 74.14 (18.85) | 80.12 (10.56) | 0.139 |
Raw(% of predicted) | 105.38 (31.38) | 99.46 (26.32) | 108.03 (33.38) | 0.524 |
R5(% of predicted) | 126.64 (29.45) | 118.75 (29.98) | 130.00 (28.96) | 0.072 |
R20(% of predicted) | 132.76 (30.95) | 120.15 (31.46) | 138.12 (29.50) | 0.024* |
Pi max (% of predicted) | 76.16 (24.28) | 80.49 (29.24) | 74.26 (21.93) | 0.382 |
Pe max (% of predicted) | 102.73 (32.68) | 98.00 (27.11) | 104.80 (34.96) | 0.637 |
6MWD, m | 561.97 (45.29) | 517.43 (44.55) | 573.52 (38.38) | 0.012* |
6MWD (% predicted) | 94.61 (6.55) | 88.46 (7.61) | 96.20 (5.31) | 0.011* |